Preventive therapy for non‐steroidal anti‐inflammatory drug‐induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled‐study of the preventive effects of lansoprazole or famotidine
Open Access
- 7 June 2005
- journal article
- clinical trial
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 21 (s2), 67-72
- https://doi.org/10.1111/j.1365-2036.2005.02477.x
Abstract
Background : There is a lack of evidence for the efficacy of preventive medications for peptic ulcers (PUs) among long‐term users of non‐steroidal anti‐inflammatory drugs (NSAIDs) in Japan. Aim : To estimate the preventive effect by normal dose, not high‐dose histamine‐H2 receptor antagonists (H2RA) for NSAID‐induced ulcers. Methods : We designed two different studies to assess the efficacy of anti‐ulcer agents in rheumatoid arthritis (RA) in patients treated over a long term with NSAIDs. An investigative survey divided patients into those not taking anti‐ulcer agents (non‐medication group); those taking mucosal protective agents (mucosal protectant group), H2RA (H2RA group), proton pump inhibitors (PPI group), or a prostaglandin E1 analog (PG) (PG group). The second study compared prospectively the preventive effects of either famotidine 20 mg bd (famotidine group) or lansoprazole 15 mg daily (lansoprazole group) in patients with PU scars. Results : The prevalence of PU in the H2RA group was significantly lower compared to the mucosal protectant group (P < 0.05), and the mucosal protectant group was not significantly different to the non‐medication group. The prospective study revealed that the PU onset rate of the famotidine group was 8% (1/13), and lansoprazole group was 15% (2/13), indicating no significant differences between the two. Conclusions : In Japan, normal‐dose H2RA is expected to be a new PU preventive treatment strategy in patients requiring long‐term NSAID therapy.Keywords
This publication has 21 references indexed in Scilit:
- Implications of corpus gastritis, atrophy and cyclooxygenase in the development of gastric erosions after curing Helicobacter pylori infectionDigestive and Liver Disease, 2005
- Gastric Mucosal Defences in the ElderlyGerontology, 1999
- Omeprazole Compared with Misoprostol for Ulcers Associated with Nonsteroidal Antiinflammatory DrugsNew England Journal of Medicine, 1998
- A Comparison of Omeprazole with Ranitidine for Ulcers Associated with Nonsteroidal Antiinflammatory DrugsNew England Journal of Medicine, 1998
- Famotidine for the Prevention of Gastric and Duodenal Ulcers Caused by Nonsteroidal Antiinflammatory DrugsNew England Journal of Medicine, 1996
- Consensus conference. Medical treatment of peptic ulcer disease. Practice guidelines. Practice Parameters Committee of the American College of GastroenterologyJAMA, 1996
- Misoprostol coadministered with diclofenac for prevention of gastroduodenal ulcersDigestive Diseases and Sciences, 1995
- Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugsThe Lancet, 1994
- Misoprostol Compared with Sucralfate in the Prevention of Nonsteroidal Anti-inflammatory Drug-induced Gastric UlcerAnnals of Internal Medicine, 1991
- Non-steroidal anti-inflammatory drugs and pain free peptic ulceration in the elderly.BMJ, 1988